Simnova, Orna Expand Partnership to Develop BCMA-Targeted RNA Therapies
CompanyDeals

Simnova, Orna Expand Partnership to Develop BCMA-Targeted RNA Therapies

Johnson & Johnson Reports Q4 Growth, Projects 2025 Sales Outlook
Company

Johnson & Johnson Reports Q4 Growth, Projects 2025 Sales Outlook

YolTech Initiates Study for YOLT-204 in Transfusion-Dependent Beta-Thalassemia
CompanyDrug

YolTech Initiates Study for YOLT-204 in Transfusion-Dependent Beta-Thalassemia

Haichang Bio's siRNA Drug HC016 Cleared for US Clinical Trials
CompanyDrug

Haichang Bio’s siRNA Drug HC016 Cleared for US Clinical Trials

iMBIORAY Raises RMB 100 Million in Series A+ for NK Cell Therapies
CompanyDeals

iMBIORAY Raises RMB 100 Million in Series A+ for NK Cell Therapies

Abbott Labs Posts Q4 Growth, Projects Strong 2025 Outlook
CompanyDrug

Abbott Labs Posts Q4 Growth, Projects Strong 2025 Outlook

Shenzhen TargetRx Raises $50M in Series C Financing for Global Clinical Trials
CompanyDeals

Shenzhen TargetRx Raises $50M in Series C Financing for Global Clinical Trials

Haisco's HSK44459 Approved for Clinical Trials in Behcet's Disease
CompanyDrug

Haisco’s HSK44459 Approved for Clinical Trials in Behcet’s Disease

Fosun's Plan to Take Henlius Private Fails After Shareholder Vote
CompanyDeals

Fosun’s Plan to Take Henlius Private Fails After Shareholder Vote

Belief BioMed's BBM-D101 Receives FDA Approval for DMD Clinical Trial
CompanyDrug

Belief BioMed’s BBM-D101 Receives FDA Approval for DMD Clinical Trial

Roche's cobas liat STI Assay Panels Gain FDA Approval and CLIA Waiver
CompanyMedical Device

Roche’s cobas liat STI Assay Panels Gain FDA Approval and CLIA Waiver

CompanyDrug

United Laboratories’ UBT251 Approved for Phase II Trials in Chronic Kidney Disease